NCT06157450View on ClinicalTrials.gov

Pharmacokinetics of ZSP1273 in Elder Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 11, 2023

Primary Completion Date

November 1, 2023

Study Completion Date

November 17, 2023

Conditions
Elder
Interventions
DRUG

ZSP1273

Participants receive ZSP1273 orally.

Trial Locations (1)

Unknown

Sir Run Run Hospital, Nanjing

All Listed Sponsors
lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY

NCT06157450 - Pharmacokinetics of ZSP1273 in Elder Participants | Biotech Hunter | Biotech Hunter